Affiliated to the Institute of Clinical Physiology of the Italian National Research Council.
Immunological evaluation of the new stable ultrasound contrast agent LK565: a phase one clinical trial
Ultrasound contrast agents (UCAs) allow the enhancement of vascular definition, thereby providing more diagnostic information. LK565 is a new second-generation UCA based on synthetic polymers of aspartic acid ...
Citation: Cardiovascular Ultrasound 2004 2:16